Kforce vs TrueBlue
KFRC and TBI side by side, both in personnel supply services. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How KFRC and TBI compare
Kforce is the larger company, worth 2.6 times as much as TrueBlue ($1.0B against $378M).
TrueBlue grew revenue faster over the last twelve months (12.4% versus 2.1% for Kforce).
Kforce keeps more of each dollar of sales as profit, with a net margin of 3.0% compared with −2.6% at TrueBlue.
Kforce pays a dividend yielding 2.8%; TrueBlue does not pay one.
Kforce scores higher on the StockData Score (17 against 6 for TrueBlue), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | KFRC | TBI |
|---|---|---|
| Size and price | ||
| Market cap | $1.0B | $378M |
| Share price | $55.85 | $12.41 |
| Change, 1 year | 80.0% | 141% |
| Change, 5 years | −29.3% | −52.8% |
| Beta (5Y) | 0.75 | 1.17 |
| Employees | 1,600 | 3,500 |
| StockData Score | ||
| Total score | 17 (better) | 6 |
| Valuation score | 0 | 2 (better) |
| Growth score | 4 (better) | 1 |
| Performance score | 4 (better) | 0 |
| Health score | 6 (better) | 3 |
| Dividend score | 3 (better) | 0 |
| Valuation | ||
| P/E | 23.4× | – |
| P/S | 0.7× | 0.2× (better) |
| P/B | 7.3× | 1.4× (better) |
| EV/EBITDA | 14.9× | – |
| P/FCF | 116× | – |
| FCF yield | 0.86% (better) | −19.1% |
| Fair value | $45.53 | $14.77 |
| Margin of safety | −22.7% | 16.0% (better) |
| Growth | ||
| Revenue growth (TTM) | 2.1% | 12.4% (better) |
| Revenue growth, 5Y average | −1.0% (better) | −2.6% |
| Net income growth (TTM) | 0.33% | – |
| EPS growth (TTM) | 5.8% | – |
| EPS growth, 5Y average | −5.6% | – |
| Profitability | ||
| Gross margin | 27.8% (better) | 20.6% |
| Operating margin | 4.5% (better) | −2.0% |
| Net margin | 3.0% (better) | −2.6% |
| FCF margin | 0.63% (better) | −4.1% |
| Return on equity | 30.5% (better) | −15.9% |
| Return on invested capital | 32.4% (better) | −8.6% |
| Financial health | ||
| Debt / equity | 0.00 | 0.38 (better) |
| Current ratio | 1.95 | 2.33 (better) |
| Altman Z-score | 7.88 (better) | 4.02 |
| Piotroski F-score | 5 (better) | 4 |
| Dividends and buybacks | ||
| Dividend yield | 2.8% | – |
| Payout ratio | 65.9% | – |
| Years of dividend growth | 8 | – |
| Dividend growth, 5Y average | 14.3% | – |
| Buyback yield | 2.5% | – |
| Shareholder yield | 5.3% (better) | 0.00% |
| Ownership | ||
| Held by institutions | 95.7% | 85.1% |
| Held by insiders | 7.5% | 7.7% |
| Insider net buying, 12 months | −$578K | −$35.6K (better) |
| Short interest, % of float | 8.7% | 1.6% |
Go deeper
- KFRC stock overview
- KFRC income statement
- KFRC valuation and score
- TBI stock overview
- TBI income statement
- TBI valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.